![](/images/graphics-bg.png)
The Reasons for Discontinuation of Infliximab Treatment in Patients with Crohn's Disease : A Review of Practice at NHS Teaching Hospital
المؤلفون المشاركون
Kennedy, Hugh J.
Krupa, Lukasz Z.
Hart, Andrew R.
Jamieson, Crawford P.
Fisher, Nicola
المصدر
العدد
المجلد 2011، العدد 2011 (31 ديسمبر/كانون الأول 2011)، ص ص. 1-3، 3ص.
الناشر
Hindawi Publishing Corporation
تاريخ النشر
2011-10-26
دولة النشر
مصر
عدد الصفحات
3
التخصصات الرئيسية
الملخص EN
Introduction.
There is little information on the reasons for discontinuing infliximab treatment in patients with Crohn's disease.
The aim of this study was to document these reasons to determine if any were preventable which would allow patients to continue the therapy.
Aims & Methods.
A review of the medical notes was conducted at the Norfolk and Norwich University Hospital on patients with Crohn's disease treated with infliximab between 2002–2008 to determine the reasons for stopping it.
Results.
A total of 65 patients were identified who had treatment with infliximab, of whom 23 (35.3%) had their therapy stopped.
The reasons for discontinuation of infliximab in the 23 patients were: 47.8% side effects, 17.4% refractory disease, 13.0% achieved remission and did not receive long-term maintenance treatment, 4.34% pregnancy, 4.34% death, and unknown 13.0%.
Conclusions.
The main reasons for the discontinuation of infliximab were side effects rather than a lack of clinical response.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Krupa, Lukasz Z.& Kennedy, Hugh J.& Jamieson, Crawford P.& Fisher, Nicola& Hart, Andrew R.. 2011. The Reasons for Discontinuation of Infliximab Treatment in Patients with Crohn's Disease : A Review of Practice at NHS Teaching Hospital. ISRN Gastroenterology،Vol. 2011, no. 2011, pp.1-3.
https://search.emarefa.net/detail/BIM-489251
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Krupa, Lukasz Z.…[et al.]. The Reasons for Discontinuation of Infliximab Treatment in Patients with Crohn's Disease : A Review of Practice at NHS Teaching Hospital. ISRN Gastroenterology No. 2011 (2011), pp.1-3.
https://search.emarefa.net/detail/BIM-489251
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Krupa, Lukasz Z.& Kennedy, Hugh J.& Jamieson, Crawford P.& Fisher, Nicola& Hart, Andrew R.. The Reasons for Discontinuation of Infliximab Treatment in Patients with Crohn's Disease : A Review of Practice at NHS Teaching Hospital. ISRN Gastroenterology. 2011. Vol. 2011, no. 2011, pp.1-3.
https://search.emarefa.net/detail/BIM-489251
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references
رقم السجل
BIM-489251
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)